J.D. Irvin -- Purification and Partial Characterization of the Antiviral Protein from Phytolacca americana which inhibits Eukaryotic Protein Synthesis; Arch. Biochem. Biophys., 169, 522-528 (1975). |
K.C. Halling et al. -- Genomic Cloning and Characterization of a Ricin Gene from Ricinus communis; Nucleic Acid Res., 13, 8019-8033 (1985). |
J. Katoaka et al. -- DNA Sequence of Mirabilis Antiviral Protein (MAP), a Ribosome-inactivating Protein with an Antiviral Property, from Mirabilis jalapa L. and Its Expression in Escherichia coli; J. Biol. Chem., 266, 8426-8430 (1991). |
X. Zhang et al. -- Homology of Trichosanthin and Ricin A Chain; Nature, 321, 477-478 (1986). |
Y.Endo et al. -- The RNA N-Glycosidase Activity of Ricin A-Chain; J. Biol. Chem., 263, 8735-8739 (1988). |
J.D. Irvin et al. -- Purification and Properties of a Second Antiviral Protein from Phytolacca americana Which inactivates Eukaryotic Ribosomes: Arch. Biochem. Biophys., 200, 418-425 (1980). |
B. Jansen et al. -- Establishment of a Human t(4;11) Leukemia in Severe Combined Immunodeficient Mice and successful Treatment Using Anti-CD19 (B43)-Pokeweed Antiviral Protein Immunotoxin; Cancer Res., 52, 406-412 (1992). |
Y.W. Kim et al. -- Immunoconjugates That Neutralize HIV Virions Kill T cells infected with Diverse Strains of HIV-1: J.Immunol., 144, 1257-1262 (1990). |
D.E. Myers et al. -- Production of a Pokeweed Antiviral Protein(PAP)-containing Immunotoxin, B43-PAP, Directed Against the CD19 Human B Lineage Lymphoid Differentiation Antigen in Highly Purified Form for Human Clinical Trails; J. Immunol. Methods, 136, 221-238 (1991). |
M.P. Ready et al. -- Extracellular Location of Pokeweed Antiviral Protein; Proc. Natl. Acad. Sci. USA, 83, 5053-5056 (1986). |
Q. Lin et al. -- Isolation and characterization of a cDNA Clone Encoding the Anti-viral Protein from Phytolacca americana; Plant Mol. Biol., 17, 609-614 (1991). |